October 1, 2026
R1 Therapeutics
R1 Therapeutics, a Redwood City, Calif.-based kidney disease biopharma, raised $3 million in Series A extension funding.
- Round
- Series A
- Amount raised
- $3M
- Lead investor
- Samsara BioCapital
- Industry
- Kidney disease biopharma
- Headquarters
- Redwood City
- Employees
- 2-10 employees
- Website
- r1therapeutics.com
- View profile →
Source: Axios Pro Rata